Healthcare Triangle Acquires Teyame AI to Enhance AI Solutions and Global Expansion

Healthcare Triangle Expands AI Capabilities with Strategic Acquisition

Healthcare Triangle, Inc. (Nasdaq: HCTI), a prominent player in digital transformation solutions for the healthcare and life sciences sectors, takes a significant step towards enhancing its technological portfolio by entering into a Definitive Agreement to acquire Teyame AI LLC. This acquisition, which includes Teyame 360 SL and Datono Mediacion SL—two companies based in Spain that specialize in AI-powered omnichannel customer experience solutions—holds a total consideration of approximately $50 million. The deal, pending shareholder approval, is expected to close on January 29, 2026, with an effective date set for January 1, 2026. This strategic move marks HCTI's transition from a traditional healthcare IT provider to a more comprehensive digital innovator.

The financial implications of this acquisition are noteworthy, as the assets from Teyame are projected to generate around $32 million in incremental annual revenue and approximately $3.6 million in EBITDA for fiscal year 2025. David Ayanoglou, HCTI's Chief Financial Officer, emphasizes that the integration of Teyame’s AI capabilities will fundamentally transform the company's operations. This initiative is not just about financial growth; it signifies HCTI's commitment to real-world applications of artificial intelligence in healthcare, ultimately aiming to deliver improved services and efficiencies across the sector.

Sujatha Ramesh, HCTI's Chief Operating Officer, underscores the strategic vision behind this acquisition, which involves creating a next-generation intelligent ecosystem for both patients and healthcare providers. By expanding its SaaS footprint into Europe and Latin America, HCTI aims to leverage Teyame's technology to enhance patient engagement and care management on a global scale. This acquisition aligns seamlessly with HCTI's broader strategy focused on AI-driven healthcare innovation and positions the company to capitalize on high-growth international markets, reinforcing its commitment to delivering digital-first healthcare solutions.

In addition to the financial and operational benefits, this acquisition showcases HCTI's dedication to advancing the healthcare landscape through innovative technology. By integrating its healthcare technology expertise with Teyame's AI automation capabilities, HCTI is poised to enhance the overall patient and provider experience significantly. This strategic alignment is expected to play a crucial role in the company's future growth trajectory.

Overall, the acquisition of Teyame AI LLC represents a pivotal development for Healthcare Triangle, reinforcing its strategic focus on AI-driven solutions and digital innovation in the healthcare sector. The anticipated benefits from this acquisition not only highlight HCTI's growth ambitions but also signify a transformative shift in how technology can enhance healthcare delivery and engagement.